Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
This is a multicenter, open, single-arm, phase I/II study to evaluate the efficacy and safety of regorafenib plus raltitrexed as third-line treatment in patients with advanced colorectal cancer.
创建时间：
2022-07-15
